Product analysis
Omega-3 2400 mg may offer small improvements in joint comfort for some people, although findings are mixed. The oil’s form is unspecified, which limits comparisons of absorption with other omega-3 supplements.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
The omega-3 molecular form is unspecified. Identifying EPA and DHA does not establish the oil structure or its absorption potential.
Ingredient Transparency63
The serving amounts are disclosed, including EPA and DHA quantities. The oil’s molecular form remains unspecified, leaving an important comparison detail unresolved.
Value For Money100
The EPA and DHA amount compares favorably on cost. That supports value for buyers seeking these omega-3 fats.
Customer Satisfaction75
Customer feedback is strongly positive across a moderate number of ratings. The feedback describes satisfaction and does not establish effectiveness.
Product Focus78
The formula centers on omega-3 fats with potential relevance to joint comfort and selected skin or metabolism outcomes. Findings vary by population and preparation, so benefits remain uncertain.
- Format
Softgel - Container
- 120 Softgel(s)
- Per serving
- $0.44
- Customer rating
- 4.8 · 205 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Calories | 30 Calorie(s) | |
Total Fat | 3.5 Gram(s) | |
Omega-3 Fatty Acids | 2400 mg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability24
Molecular Form & Absorption Potential
Source Purity & Oxidative Protection
Dose, Safety & Label Transparency43
EPA & DHA Label Specificity
Active Ingredient Concentration
Third-Party Purity Verification
Value100
Price per 1000mg of EPA+DHA
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Supplementation of fish oil and olive oil in patients with rheumatoid arthritis.
- Krill oil improved osteoarthritic knee pain in adults with mild to moderate knee osteoarthritis: a 6-month multicenter, randomized, double-blind, placebo-controlled trial.
- Effects of omega-3 supplementation on lipid metabolism, inflammation, and disease activity in rheumatoid arthritis: a meta-analysis of randomized controlled trials.
- Impact of type and dose of oral polyunsaturated fatty acid supplementation on disease activity in inflammatory rheumatic diseases: a systematic literature review and meta-analysis.
- A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain.
- Effects of omega-3 supplementation on glucose and lipid metabolism in patients with gestational diabetes: A meta-analysis of randomized controlled trials.
- Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism.
- Clinical and metabolic response to flaxseed oil omega-3 fatty acids supplementation in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial.
- The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
- A combination of omega-3 and plant sterols regulate glucose and lipid metabolism in individuals with impaired glucose regulation: a randomized and controlled clinical trial.
- Dietetic intervention in psoriatic arthritis: the DIETA trial.
- Omega-3 fatty acid supplement skin cancer prophylaxis in lung transplant recipients: A randomized, controlled pilot trial.
- Treatment of hard-to-heal wounds in ischaemic lower extremities with a novel fish skin-derived matrix.
- Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers.